Groenwoud A F, Persijn G G, Hendriks G F, D'Amaro J, Cohen B
Eurotransplant Foundation, University Hospital, Leiden, The Netherlands.
Transplant Proc. 1987 Feb;19(1 Pt 1):699-701.
Results in this study demonstrate that HLA matching has a beneficial effect on the survival of renal allograft in pediatric recipients. The introduction of a child-match procedure may have led to a lower degree of HLA well-matched grafts because of the small size of the pediatric waiting list. The poor results obtained in the group of children aged less than 6 years may have been due to a difference in physical condition at the moment of transplantation. This may explain why 4 of 20 (20%) of the failures in that age-group were due to patient death. The best results with the child-match procedure were obtained if the donor and recipient were both aged between 6 and 15 years. The overall graft survival in all children was improved by the use of Cs. An increase of approximately 10% was observed in this group of patients. The numbers in this group are too small, however, to permit any meaningful analysis of the influence of Cs on HLA matching. Finally, the overall results in this report demonstrate that renal transplantation is an effective form of therapy for end-stage renal disease in children.
本研究结果表明,HLA配型对小儿肾移植受者的肾移植存活率有有益影响。由于小儿等待名单规模较小,采用儿童配型程序可能导致HLA高度匹配的移植物比例较低。6岁以下儿童组的不良结果可能是由于移植时身体状况的差异。这或许可以解释为何该年龄组20例(20%)移植失败中有4例是因患者死亡。如果供体和受体年龄均在6至15岁之间,采用儿童配型程序可获得最佳结果。使用环孢素(Cs)提高了所有儿童的总体移植物存活率。在该组患者中观察到存活率提高了约10%。然而,该组病例数过少,无法对环孢素对HLA配型的影响进行任何有意义的分析。最后,本报告的总体结果表明,肾移植是治疗儿童终末期肾病的一种有效疗法。